Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Fahn

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2023
Association of Rare Variants in ARSA with Parkinson's DiseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
Annals of Neurology|October 7, 2004
Huntington's Disease-like 2 (HDL2) in North America and JapanRussell L Margolis, Susan E Holmes, Adam Rosenblatt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Brain : a Journal of Neurology|November 12, 2022
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's diseaseKonstantin Senkevich, Cornelia E Zorca, Aliza Dworkind, et al.
Archives of Neurology|September 15, 2010
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease studyRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2014
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD studyMadeleine E Sharp, Elise Caccappolo, Helen Mejia-Santana, et al.
Molecular Neurodegeneration|December 19, 2024
Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Nathan Karpilovsky, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2023
Association of Rare Variants in ARSA with Parkinson's DiseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
Annals of Neurology|October 7, 2004
Huntington's Disease-like 2 (HDL2) in North America and JapanRussell L Margolis, Susan E Holmes, Adam Rosenblatt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Brain : a Journal of Neurology|November 12, 2022
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's diseaseKonstantin Senkevich, Cornelia E Zorca, Aliza Dworkind, et al.
Archives of Neurology|September 15, 2010
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease studyRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2014
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD studyMadeleine E Sharp, Elise Caccappolo, Helen Mejia-Santana, et al.
Molecular Neurodegeneration|December 19, 2024
Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Nathan Karpilovsky, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
Pageof 17